Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mirae Asset Venture Investment is a leading Korean venture capital and private equity firm investing in early-stage and growth companies across sectors including biotechnology, IT, and consumer industries. It manages multiple funds and provides management consulting as well as investment services to startups and SMEs domestically and internationally. The company itself does not develop drugs or have a clinical pipeline; it invests in companies that do. For direct biotech/life science investment activities under the "Mirae Asset" brand in the US, see "Mirae Asset Capital Life Science," which operates as an affiliate focused on private biotech investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mirae Asset Venture Investment.